Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: A randomised controlled trial

Lancet

Volumn 366, Issue 9491, 2005, Pages 1085-1093

  Saha, Debasish ^a,e   Khan, Wasif A ^a   Karim, Mohammad M ^a   Chowdhury, Hafizur R ^a   Salam, Mohammed A ^a   Bennish, Michael L ^b,c,d  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ICDDRB Clinical Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN;

ADOLESCENT; ARTICLE; CHILD; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION; TREATMENT OUTCOME; VIBRIO CHOLERAE; VOMITING;

EID: 25144519212     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67290-X     Document Type: Article

References (33)

1. WB Greenough, RS Gordon, IS Rosenberg, BI Davies, AS Benenson Tetracycline in the treatment of cholera Lancet 41 1964 355 357
2. WA Khan, M Begum, MA Salam, PK Bardhan, MR Islam, D Mahalanabis Comparative trial of five antimicrobial compounds in the treatment of cholera in adults Trans R Soc Trop Med Hyg 89 1995 103 106
3. SK Roy, A Islam, R Ali A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children Trans R Soc Trop Med Hyg 92 1998 460 462
4. World Health Organization The treatment of diarrhoea: a manual for physicians and other senior health workers http://www.who.int/child-adolescent- health/New_Publications/CHILD_HEALTH/ISBN_92_4_159318_0.pdf (accessed Aug 20, 2005)
5. DA Sack, S Islam, H Rabbani, A Islam Single-dose doxycycline for cholera Antimicrob Agents Chemother 14 1978 462 464
6. GH Rabbani, MR Islam, T Butler, M Shahrier, K Alam Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial Antimicrob Agents Chemother 33 1989 1447 1450
7. MR Islam Single dose tetracycline in cholera Gut 28 1987 1029 1032
8. AN Alam, NH Alam, T Ahmed, DA Sack Randomised double blind trial of single dose doxycycline for treating cholera in adults BMJ 300 1990 1619 1621
9. WA Khan, ML Bennish, C Seas Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139 Lancet 348 1996 296 300
10. GH Rabbani, T Butler, M Shahrier, R Mazumdar, MR Islam Efficacy of a single dose of furazolidone for treatment of cholera in children Antimicrob Agents Chemother 35 1991 1864 1867
11. MK Bhattacharya, D Dutta, T Ramamurthy, D Sarkar, A Singharoy, SK Bhattacharya Azithromycin in the treatment of cholera in children Acta Paediatr 92 2003 676 678
12. WA Khan, D Saha, A Rahman, MA Salam, J Bogaerts, ML Bennish Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial Lancet 360 2002 1722 1727
13. RI Glass, I Huq, AR Alim, M Yunus Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh J Infect Dis 142 1980 939 942
14. E Gotuzzo, C Seas, J Echevarria, C Carrillo, R Mostorino, R Ruiz Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults Clin Infect Dis 20 1995 1485 1490
15. R Grady Safety profile of quinolone antibiotics in the pediatric population Pediatr Infect Dis J 22 2003 1128 1132
16. CP Doherty, SK Saha, WA Cutting Typhoid fever, ciprofloxacin and growth in young children Ann Trop Paediatr 20 2000 297 303
17. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children Pediatr Infect Dis J 21 2002 1136 1141
18. LL Thomsen, A Paerregaard Treatment with ciprofloxacin in children with typhoid fever Scand J Infect Dis 30 1998 355 357
19. National Centre for Health Statistics growth charts http://www.cdc.gov/ nchs/data/nhanes/growthcharts/zscore/zwtage.txt (accessed Aug 22, 2005)
20. CP Farrington, G Manning Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk Stat Med 9 1990 1447 1454
21. UH Stroeher, LE Karageorgos, R Morona, PA Manning Serotype conversion in Vibrio cholerae O1 Proc Natl Acad Sci USA 89 1992 2566 2570
22. J Lindenbaum, WB Greenough, MR Islam Antibiotic therapy of cholera in children Bull World Health Organ 37 1967 529 538
23. AW Karchmer, GT Curlin, MI Huq, N Hirschhorn Furazolidone in paediatric cholera Bull World Health Organ 43 1970 373 378
24. I Kabir, WA Khan, R Haider, AK Mitra, AN Alam Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children J Diarrhoeal Dis Res 14 1996 243 247
25. R Slinger, M Desjardins, AE McCarthy Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series BMC Infect Dis 4 2004 36
26. MM Levine, JB Kaper, D Herrington Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques Infect Immun 56 1988 161 167
27. MM Levine, JB Kaper, D Herrington Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR Lancet 2 1988 467 470
28. RI Glass, AM Svennerholm, MR Khan, S Huda, MI Huq, J Holmgren Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection J Infect Dis 151 1985 236 242
29. J Echevarria, C Seas, C Carrillo, R Mostorino, R Ruiz, E Gotuzzo Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera Clin Infect Dis 20 1995 1480 1484
30. R Gupta, JY Kim, MA Espinal Public health: responding to market failures in tuberculosis control Science 293 2001 1049 1051
31. ICDDR,B Emergence of a unique, multi-drug resistant strain of Vibrio cholerae O1 in Bangladesh Health Sci Bull 3 2005 1 20 http://www.icddrb.org/pub/ publication.jsp?classificationID=56&pubID=6298 (accessed Aug 26, 2005)
32. P Garg, S Chakraborty, I Basu Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-97 in Calcutta, India Epidemiol Infect 124 2000 393 399
33. MV Jesudason, V Balaji, CJ Thomson Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore Indian J Med Res 116 2002 96 98